Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 433–456 of 4,439 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Reports Clear all

Conditions: ECT, Treatment Resistant Depression
Interventions: Electroencephalographic (EEG), Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR16), Ictal Electroencephalographic (EEG) Measurements, Post-Ictal Electroencephalographic (EEG) Suppression Measurements; Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Postoperative Pain, Postoperative Edema, Postoperative Ecchymosis, Surgical Wound Healing, Postsurgical Recovery
Interventions: Perioperative photobiomodulation light therapy; Other
Lead sponsor: Elixir MD Inc; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Irvine, California

Conditions: Epilepsy
Interventions: diazepam nasal spray; Drug
Lead sponsor: Acorda Therapeutics; Industry
Eligibility: 12 Years to 65 Years
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 33
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 26 more

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: cisplatin, everolimus, gene expression analysis, immunohistochemistry staining method, laboratory biomarker analysis, pharmacological study, biopsy; Drug · Genetic · Other + 1 more
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Antibiotic Stewardship
Interventions: Opt-Out Protocol; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 762 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 10
States / cities: Atlanta, Georgia • Fayetteville, Georgia • Newnan, Georgia + 6 more

Conditions: Tobacco Use Cessation, Tobacco Use Disorder, Nicotine Dependence, Smokeless Tobacco Use
Interventions: QuitAid (pharmacist-delivered MTM), Nicotine Replacement Therapy (NRT); Behavioral · Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Hereditary Disease, Genetic Predisposition to Disease
Interventions: Genomic sequencing, Family history report; Genetic · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: Not listed
Enrollment: 1,205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Substance-related Disorders
Interventions: Implementation Facilitation; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 3,838 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 4
States / cities: Hartford, Connecticut • New Haven, Connecticut • Brooklyn, New York + 1 more

Conditions: Cardiovascular Disease
Interventions: SLCO1B1 Genotype; Genetic
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years to 75 Years
Enrollment: 408 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Urinary Tract Infections, Prostatitis, Interstitial Cystitis
Interventions: Guidance 4.0 PCR test, Urine Culture; Diagnostic Test
Lead sponsor: Pathnostics; Industry
Eligibility: 18 Years and older
Enrollment: 2,511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Cerebral Cavernous Malformation
Interventions: Atorvastatin, Placebo; Drug · Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Healthy Volunteers
Interventions: Propofol - Emergence-from-LOR Protocol, Propofol - Light Sedation Protocol; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Diabetes Mellitus, Type 1
Interventions: Type 1 Diabetes and Life; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 3
States / cities: Stanford, California • Syracuse, New York • Houston, Texas

Conditions: Physical Trauma
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 31 Days to 89 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 3
States / cities: Aurora, Colorado • Denver, Colorado • San Antonio, Texas

Conditions: Cervical Cancer, Lung Cancer, Prostate Cancer, Vaginal Cancer, Ovarian Cancer, Breast Cancer, Bladder Cancer
Interventions: Questioners, STAR website; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1,007 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Atopic Dermatitis, Eczema, DNA
Interventions: DNA reports, Information reports; Behavioral
Lead sponsor: Studies&Me; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Hypertension, Smoking Cessation
Interventions: Data, Panel Management Support, Education; Other
Lead sponsor: VA New York Harbor Healthcare System; Federal
Eligibility: Not listed
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 2
States / cities: Brooklyn, New York • New York, New York

Conditions: Schizophrenia, Bipolar Disorder, Major Depression
Interventions: Person-Centered Care, Measurement-Based Care; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 2,443 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Lebanon, New Hampshire • Pittsburgh, Pennsylvania

Conditions: Cancer
Interventions: SOZO Device, DEXA Scan; Device
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Sacroiliac Joint, Pain, Pelvis
Interventions: SI Screw Removal Surgery, Non-screw removal treatment (non-operative management); Procedure
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Corticobasal Syndrome, Upper Extremity Dysfunction
Interventions: Patterned Sensory Enhancement (PSE), Transcranial Direct Current Stimulation (tDCS); Behavioral · Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Smoking Cessation
Interventions: SmokefreeTXT, Smartband; Other · Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Alcohol Use, Unspecified
Interventions: Deviance Regulation Theory; Behavioral
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years to 21 Years
Enrollment: 157 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Cancer
Interventions: Patient Navigator (PN), Baseline Questionnaire, Follow-up Questionnaire, Patient Navigator Satisfaction Survey; Behavioral · Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years to 39 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Tampa, Florida

Search by objective public record fields.

CET- REM (Correlating ECT Response to EEG Markers)

Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD Use

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors

The DETOURS Trial: De-escalating Empiric Treatment: Opting Out of Rx for Selected Patients With Suspected Sepsis - Opt-Out Protocol Trial

Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid

Genomic Sequencing for Childhood Risk and Newborn Illness

Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation

Integrating Pharmacogenetics In Clinical Care

Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study

Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

Induction of Dreaming With EEG and Anesthesia in Healthy Adults

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Validation of Lower Body Negative Pressure (LBNP) Model of Human Hemorrhage in Trauma Patients

Internet-based System for Cancer Patients to Self-report Toxicity

Using a Telemedicine Approach in a Genome-wide Association Study of Atopic Dermatitis - Searching for Novel Biomarkers in Clinically Relevant Phenotypes

Program for Research on the Outcomes of VA Education

Person-Centered Versus Measurement-Based Care in Mental Health

Body Composition During Cancer Treatment

Sacroiliac (SI) Screws: The Effect of SI Screw Removal on Patient-Reported Pain and Functional Outcomes

Music and Brain Stimulation for Upper Extremity Performance in Patients With Corticobasal Syndrome

Quit Smoking Text Message Study

Longitudinal Use of Protective Behavioral Strategies

Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population